Smart Infusion Pumps Market Report 2026

Smart Infusion Pumps Market Overview

• Smart Infusion Pumps market size has reached to $8.88 billion in 2025 • Expected to grow to $13.84 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Rising Prevalence Of Chronic Diseases Driving Market Growth Through Advanced Medication Delivery Solutions • Market Trend: ICU Medical's FDA-Cleared Plum Duo Infusion Pump With LifeShield Software Enhances Smart Infusion Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Smart Infusion Pumps Market?

Smart infusion pumps are advanced versions of traditional infusion pumps, integrated with software and sometimes even connected systems, designed to enhance the safety and efficiency of drug delivery. They are equipped with drug libraries, alarms, and other sophisticated features, enabling them to reduce human errors and increase the safety of the medication administration process. The main types of smart infusion pumps are large volumetric infusion pumps, patient-controlled analgesia pumps, syringe infusion systems, electronic ambulatory infusion systems, implantable infusion systems, MRI-compatible IV infusion pump systems, disposable elastomeric infusion systems, and others. Large volumetric infusion pumps are specifically designed to accurately deliver substantial volumes of fluids, medications, or nutrients into a patient's bloodstream at controlled rates. These pumps incorporate a range of technologies such as smart pump systems, digital infusion systems, wireless infusion technologies, standard infusion mechanisms, and closed-loop systems. Their applications span across multiple medical fields, including chemotherapy or oncology, pediatrics or neonatology, gastroenterology, hematology, diabetes, and others, and are utilized in various healthcare settings, including hospitals, ambulatory surgical centers, home care, specialty clinics, and others.

What Is The Smart Infusion Pumps Market Growth Forecast?

The smart infusion pumps market size is expected to see strong growth in the next few years. It will grow to $13.84 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to development of multi-channel and programmable infusion systems, integration with electronic medical records (EMR), rising demand for home care infusion therapies, adoption of MRI-compatible and wireless infusion pumps, increasing use of digital and smart pump technologies. Major trends in the forecast period include rising adoption of smart pump technology, integration of wireless and closed-loop infusion systems, increasing use in home care and ambulatory settings, focus on reducing medication errors and enhancing patient safety, expansion of infusion pumps in specialty clinics and oncology.

Global Smart Infusion Pumps Market Segmentation

1) By Type: Large Volumetric Infusion Pumps, Patient Controlled Analgesia Pumps, Syringe Infusion Systems, Electronic- Ambulatory Infusion Systems, Implantable Infusion Systems, MRI-Compatible IV Infusion Pump Systems, Disposable Elastomeric Infusion Systems, Other Types 2) By Technology: Smart Pump Technology, Digital Infusion Systems, Wireless Infusion Systems, Standard Infusion Pumps, Closed-Loop Systems 3) By Application: Chemotherapy Or Oncology, Pediatrics Or Neonatology, Gastroenterology, Hematology, Diabetes, Other Applications 4) By End User: Hospitals, Ambulatory Surgical Centers, Home Care, Specialty Clinics, Other End User Subsegments: 1) By Large Volumetric Infusion Pumps: Single Channel Pumps, Multi-Channel Pumps, Stand-Alone Systems, Integrated Systems 2) By Patient Controlled Analgesia (PCA) Pumps: Disposable PCA Pumps, Electronic PCA Pumps 3) By Syringe Infusion Systems: Motor-Driven Syringe Systems, Spring-Driven Syringe Systems 4) By Electronic-Ambulatory Infusion Systems: Programmable Ambulatory Pumps, Non-Programmable Ambulatory Pumps 5) By Implantable Infusion Systems: Intrathecal Drug Delivery Pumps, Insulin Delivery Pumps 6) By MRI-Compatible IV Infusion Pump Systems: Shielded MRI-Compatible Pumps, Non-Shielded MRI-Compatible Pumps 7) By Disposable Elastomeric Infusion Systems: Continuous Flow Pumps, Patient-Controlled Flow Pumps 8) By Other Types: Enteral Feeding Pumps, Insulin Infusion Pumps, Chemotherapy Infusion Pumps

What Is The Driver Of The Smart Infusion Pumps Market?

The increase in chronic disease is expected to propel the growth of the smart infusion pumps market going forward. Chronic diseases are long-term health conditions that develop gradually and usually need continuous care or management over time. Chronic diseases are rising due to increasingly sedentary lifestyles that contribute to obesity, diabetes, and cardiovascular conditions. Smart infusion pumps help manage chronic diseases by delivering precise, automated medication doses, reducing human error, and improving long-term treatment outcomes. For instance, in April 2025, according to the International Diabetes Federation (IDF), a Belgium-based non-profit organization, nearly 589 million adults aged 20–79 are living with diabetes worldwide, and this number is projected to rise significantly to 853 million by 2050. Therefore, the increase in chronic disease is driving the growth of the smart infusion pumps industry.

Key Players In The Global Smart Infusion Pumps Market

Major companies operating in the smart infusion pumps market are Fresenius Kabi AG, Medtronic plc, Becton Dickinson and Company, Baxter International Inc, Terumo Corporation, Mindray Medical International Limited, Moog Inc, ICU Medical Inc, Insulet Corporation, Avanos Medical Inc, JMS Co Ltd, Vygon SA, B Braun Melsungen AG, Eitan Group, Heka Healthcare B V, PROMECON GmbH, Micrel Medical Devices SA, Smiths Medical, Zyno Medical LLC, CME Medical, Bionical Emas, Nipro Corporation

Global Smart Infusion Pumps Market Trends and Insights

Major companies operating in the smart infusion pumps market are focusing on developing innovative solutions, such as cassette-based infusion pumps, to improve medication delivery accuracy, enhance patient safety, and streamline drug administration workflows in clinical settings. Cassette-based infusion pumps refer to a type of infusion pump that uses a disposable cassette to deliver fluids or medications with high accuracy. For instance, in August 2023, ICU Medical Inc., a US-based medical technology company, received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Duo infusion pump with cloud-based LifeShield software. It features dual-channel delivery, enabling simultaneous administration of two compatible intravenous therapies, thereby enhancing workflow efficiency and patient care. It includes advanced drug library integration and automated programming, which help minimize medication errors. The LifeShield software complements the pump with real-time monitoring, data-driven insights, and clinical decision support, ensuring greater infusion safety and compliance with hospital protocols.

What Are Latest Mergers And Acquisitions In The Smart Infusion Pumps Market?

In September 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Bigfoot Biomedical for an undisclosed amount. With this acquisition, Abbott aims to enhance its diabetes care portfolio by integrating Bigfoot Biomedical’s smart insulin management technology with its FreeStyle Libre continuous glucose monitoring system to deliver a more comprehensive and connected solution for insulin-requiring patients. Bigfoot Biomedical Inc. is a US-based company that develops smart infusion pumps.

Regional Outlook

North America was the largest region in the smart infusion pumps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Smart Infusion Pumps Market?

The smart infusion pumps market includes revenues earned by entities by providing services such as equipment installation, maintenance, software updates, user training, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart infusion pumps market also includes sales of infusion pump units, syringes, pole clamps, and mounting hardware. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.